Publication | Open Access

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Tumour Necrosis FactorUrologyCancer ImmunosurveillanceGenitourinary CancerSuperficial Bladder CancerImmunologyIntravesical ImmunotherapyImmunotherapyMedicineTumor Microenvironment